Testing effectiveness (Phase 2)Ended earlyNCT03089697
What this trial is testing
Phase IIa Clinical Study of N-Rephasin® SAL200
Who this might be right for
Staphylococcus Aureus BacteremiaAnti-Bacterial Agents
Intron Biotechnology, Inc. 25
Showing 7 of 7 results